Drug Pipeline

A166 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06968585 A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive… HER2-positive Breast Cancer Active, Not Recruiting
Phase 2
NCT07299825 A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Her 2 Positive Breast Cancer Recruiting
Phase 1
NCT05311397 A Study of A166 in Patients With Advanced Solid Malignant Tumors Breast Cancer Active, Not Recruiting
Sponsors Running A166 Trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (3)
Disease Areas
Breast Cancer (3) HER2-Positive Breast Cancer (1)
Get alerts when A166 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free